FlexGen is an innovative biotech company based in Leiden, the Netherlands. FlexGen is a spin-off from Leiden University Medical Centre (LUMC) and Dutch Space (part of EADS) and has proprietary technologies for laser based in-situ synthesis of oligonucleotides and other biomolecules. FlexGen commercializes the FlexArrayer, a bench-top instrument for custom microarray and oligopool synthesis. FlexGen works at the forefront of innovative microarray and oligopool applications.
Looking for a particular FlexGen B.V. employee's phone or email?
The FlexGen B.V. annual revenue was $5.1 million in 2026.
The NAICS codes for FlexGen B.V. are [541713, 54, 54171, 541, 5417].
The SIC codes for FlexGen B.V. are [87, 873].